Journal article · 2023 · Open access

A Review of Labeling Based on Patient-Reported Outcome Endpoints for New Oncology Drugs Approved by the European Medicines Agency (2017-2021)

Ari Gnanasakthy, Courtney Levy, Lindsey Norcross, Lynda C. Doward, Randall Winnette

Value in Health, 26(6), 893–901 · Published 4 February 2023 · DOI 10.1016/j.jval.2023.01.017

Open PDFView at the publisherCite this paper

In brief

“A Review of Labeling Based on Patient-Reported Outcome Endpoints for New Oncology Drugs Approved by the European Medicines Agency (2017-2021)” is a 2023 journal article by Ari Gnanasakthy and 4 co-authors, published in Value in Health. OpenAlex counts 20 citations as of 22 November 2026. It is open access: the full text is free to read at Value in Health.

Citations
20
Most cited in
2026 (8)
Field-weighted impact
2.92
References
23
Authors
5

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Gnanasakthy, A., Levy, C., Norcross, L., Doward, L. C., & Winnette, R. (2023). A Review of Labeling Based on Patient-Reported Outcome Endpoints for New Oncology Drugs Approved by the European Medicines Agency (2017-2021). Value in Health, 26(6), 893–901. https://doi.org/10.1016/j.jval.2023.01.017

MLA 9

Gnanasakthy, Ari, et al. “A Review of Labeling Based on Patient-Reported Outcome Endpoints for New Oncology Drugs Approved by the European Medicines Agency (2017-2021).” Value in Health, vol. 26, no. 6, 2023, pp. 893–901. https://doi.org/10.1016/j.jval.2023.01.017.

Chicago

Gnanasakthy, Ari, Courtney Levy, Lindsey Norcross, Lynda C. Doward, and Randall Winnette. 2023. “A Review of Labeling Based on Patient-Reported Outcome Endpoints for New Oncology Drugs Approved by the European Medicines Agency (2017-2021).” Value in Health 26 (6): 893–901. https://doi.org/10.1016/j.jval.2023.01.017.

Harvard

Gnanasakthy, A. et al. (2023) ‘A Review of Labeling Based on Patient-Reported Outcome Endpoints for New Oncology Drugs Approved by the European Medicines Agency (2017-2021)’, Value in Health, 26(6), pp. 893–901. doi:10.1016/j.jval.2023.01.017.

IEEE

A. Gnanasakthy, C. Levy, L. Norcross, L. C. Doward, and R. Winnette, “A Review of Labeling Based on Patient-Reported Outcome Endpoints for New Oncology Drugs Approved by the European Medicines Agency (2017-2021),” Value in Health, vol. 26, no. 6, pp. 893–901, 2023, doi: 10.1016/j.jval.2023.01.017.

BibTeX

@article{gnanasakthy2023review,
  title     = {{A Review of Labeling Based on Patient-Reported Outcome Endpoints for New Oncology Drugs Approved by the European Medicines Agency (2017-2021)}},
  author    = {Gnanasakthy, Ari and Levy, Courtney and Norcross, Lindsey and Doward, Lynda C. and Winnette, Randall},
  journal   = {Value in Health},
  year      = {2023},
  volume    = {26},
  number    = {6},
  pages     = {893--901},
  doi       = {10.1016/j.jval.2023.01.017},
  url       = {https://doi.org/10.1016/j.jval.2023.01.017}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202311
202455
202566
202688

Its field-weighted citation impact is 2.92: it has been cited 2.92 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life

  • patient-reported outcomes
  • drug labeling
  • oncology drug approval
  • European Medicines Agency
  • health-related quality of life
  • open-label study
  • regulatory language

Work with this paper

Most-cited papers in Economics, Econometrics and Finance

All highly cited Economics, Econometrics and Finance papers

Questions about this paper

How do I cite this paper in APA style?

Gnanasakthy, A., Levy, C., Norcross, L., Doward, L. C., & Winnette, R. (2023). A Review of Labeling Based on Patient-Reported Outcome Endpoints for New Oncology Drugs Approved by the European Medicines Agency (2017-2021). Value in Health, 26(6), 893–901. https://doi.org/10.1016/j.jval.2023.01.017

How many times has this paper been cited?

20 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Value in Health: sign in and open the PDF from this page.

Who wrote this paper?

Ari Gnanasakthy, Courtney Levy, Lindsey Norcross, Lynda C. Doward, Randall Winnette.

What is the DOI of this paper?

10.1016/j.jval.2023.01.017, permanently at https://doi.org/10.1016/j.jval.2023.01.017. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.